GSK News
GSK plc
$48.68
-$0.06(-0.12%)
43
Overall
--
Value
66
Tech
21
Quality
Market Cap
$101.22B
Volume
5.20M
52W Range
$42.85 - $61.70
Target Price
$59.53
GSK news: the latest GSK plc headlines, press releases and market updates, newest first.
Latest GSK News
- GlaxoSmithKline (GSK) Gets a Hold from Deutsche BankTipRanks Auto-Generated Intelligence Newsdesk · Oct 29, 2026
- UBS Remains a Hold on GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 29, 2026
- GSK Delivers Strong Q3 2026 Core Results and Reaffirms Full-Year Growth GuidanceTipRanks Auto-Generated Newsdesk · Oct 28, 2026
- GlaxoSmithKline (GSK) Gets a Buy from BernsteinTipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Goldsky Resources’ High-Grade Infill Drilling Bolsters Rajapalot Gold-Cobalt ResourceTipRanks Canadian Auto-Generated Newsdesk · Oct 27, 2026
- GSK Highlights Strong Phase III Osteosarcoma Data for Ris-Rez from China TrialTipRanks Auto-Generated Newsdesk · Oct 26, 2026
- GSK Reports October Executive Notional ADS Acquisition on NYSETipRanks Auto-Generated Newsdesk · Oct 26, 2026
- GSK Reports Strong Mo-Rez Phase I Data in Platinum-Resistant Ovarian CancerTipRanks Auto-Generated Newsdesk · Oct 26, 2026
- GlaxoSmithKline (GSK) Receives a Sell from J.P. MorganTipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
- RBC Capital Sticks to Its Hold Rating for GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Jefferies Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 19, 2026
- GSK Executives Reinvest Dividends in U.S.-Listed ADSTipRanks UK Auto-Generated Newsdesk · Oct 15, 2026
- GSK executives report dividend-driven increases in deferred share interestsTipRanks UK Auto-Generated Newsdesk · Oct 14, 2026
- GlaxoSmithKline (GSK) Gets a Sell from BarclaysTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- GlaxoSmithKline (GSK) Receives a Hold from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
- Berenberg Bank Keeps Their Buy Rating on GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
- Barclays Remains a Sell on GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GSK | $48.68 | -0.1% | 5.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |